(2026). Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: Research Summary. JAMA, 335(19), e264329. https://doi.org/10.1001/jama.2026.4329
Chicago Style (17th ed.) Citation"Tucidinostat Plus R-CHOP Vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: Research Summary." JAMA 335, no. 19 (2026): e264329. https://doi.org/10.1001/jama.2026.4329.
MLA (9th ed.) Citation"Tucidinostat Plus R-CHOP Vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: Research Summary." JAMA, vol. 335, no. 19, 2026, p. e264329, https://doi.org/10.1001/jama.2026.4329.
Warning: These citations may not always be 100% accurate.
